Manufacturers Notice of Application - 2020
[Federal Register Volume 85, Number 47 (Tuesday, March 10, 2020)]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-04829]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-582]
Bulk Manufacturer of Controlled Substances Application: S&B Pharma, Inc.; Correction
ACTION: Notice of application; correction.
SUMMARY: The Drug Enforcement Administration (DEA) published a document in the Federal Register on November 22, 2019, concerning a notice of application. As that document correctly indicated, the applicant, S&B Pharma, Inc., DBA Norac Pharma, 405 South Motor Avenue, Azusa, California 91702-3232 applied to be registered as a bulk manufacturer of a number of controlled substances, to include applying for authorization in order to synthetically manufacture using drug code 7360 (marihuana). However, on the notice of application published, drug code 7360 was inadvertently identified and listed as Gamma Hydroxybutyric Acid instead of Marihuana.
In the Federal Register of November 22, 2019, in FR Doc. 2019-25402 (84 FR 64563), on page 64564, correct the listing of drug code 7360 to be identified as Marihuana, as is shown below.
|Controlled Substance||Drug Code||Schedule|
Dated: February 11, 2020.
William T. McDermott,
[FR Doc. 2020-04829 Filed 3-9-20; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).